The role of screening and monitoring for bleomycin pulmonary toxicity

被引：21

作者：

Shippee, Brittney M. ^{[1
]}

Bates, Jill S. ^{[2
]}

Richards, Kristy L. ^{[3
,4
]}

机构：

[1] UAB Med, Dept Pharm, JT 1728-619 19th St South, Birmingham, AL 35249 USA

[2] Univ N Carolina, Med Ctr, Dept Pharm, Chapel Hill, NC USA

[3] Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[4] Univ N Carolina, UNC Sch Med, Div Hematol Oncol, Chapel Hill, NC USA

来源：

JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 2016年 / 22卷 / 02期

关键词：

Bleomycin; pulmonary toxicity; monitoring; risk factors; CANCER; CHEMOTHERAPY;

D O I：

10.1177/1078155215574294

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Bleomycin-induced pulmonary toxicity can have a significant impact on patient outcomes. However, no guidelines for ideal screening and monitoring are available. This paper reviews the literature to identify the best way to monitor and reduce patient risk for bleomycin pulmonary toxicity. We have created evidence-based guidelines to help healthcare professionals identify patient risk factors and provide appropriate assessment and monitoring for patients receiving bleomycin therapy.

引用

页码：308 / 312

页数：5

共 50 条

[21] ULTRASTRUCTURAL STUDY OF PULMONARY BLEOMYCIN TOXICITY
DASKAL, Y
GYORKEY, F
GYORKEY, P
BUSCH, H
CANCER RESEARCH, 1976, 36 (04) : 1267 - 1272
[22] PULMONARY TOXICITY OF CONTINUOUSLY INFUSED BLEOMYCIN
COOPER, K
HONG, WK
CLINICAL RESEARCH, 1979, 27 (05): : A759 - A759
[23] PULMONARY TOXICITY STUDIES OF BLEOMYCIN AND TALISOMYCIN
SCHLEIN, A
SCHURIG, JE
BACA, C
BRADNER, WT
CROOKE, ST
CANCER TREATMENT REPORTS, 1981, 65 (3-4): : 291 - 297
[24] ULTRASTRUCTURAL CHANGES IN PULMONARY BLEOMYCIN TOXICITY
GYORKEY, F
DASKAL, I
GYORKEY, P
LABORATORY INVESTIGATION, 1975, 32 (03) : 425 - 425
[25] BLEOMYCIN-INDUCED PULMONAR NODULES - A VARIANT OF BLEOMYCIN PULMONARY TOXICITY
ZUCKER, PK
KHOURI, NF
ROSENSHEIN, NB
GYNECOLOGIC ONCOLOGY, 1987, 28 (03) : 284 - 291
[26] Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity
Burgy, Olivier
Wettstein, Guillaume
Bellaye, Pierre S.
Decologne, Nathalie
Racoeur, Cindy
Goirand, Francoise
Beltramo, Guillaume
Hernandez, Jean-Francois
Kenani, Abderraouf
Camus, Philippe
Bettaieb, Ali
Garrido, Carmen
Bonniaud, Philippe
SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (326)
[27] PULMONARY TOXICITY AFTER RADIATION AND BLEOMYCIN - REVIEW
CATANE, R
SCHWADE, JG
TURRISI, AT
WEBBER, BL
MUGGIA, FM
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1979, 5 (09): : 1513 - 1518
[28] OXYGEN-EXACERBATED BLEOMYCIN PULMONARY TOXICITY
INGRASSIA, TS
RYU, JH
TRASTEK, VF
ROSENOW, EC
MAYO CLINIC PROCEEDINGS, 1991, 66 (02) : 173 - 178
[29] PULMONARY TOXICITY OF BLEOMYCIN - NEW PRACTICAL CONSIDERATIONS
LACCOURREYE, H
HAAS, C
BASSET, JM
HAGUET, JF
ANNALES D OTO-LARYNGOLOGIE ET DE CHIRURGIE CERVICO-FACIALE, 1977, 94 (10-1): : 571 - 582
[30] PULMONARY TOXICITY DUE TO BLEOMYCIN - REPORT OF A CASE
KROUS, HF
HAMLIN, WB
ARCHIVES OF PATHOLOGY, 1973, 95 (06): : 407 - 410

← 1 2 3 4 5 →